CD47 and hepatocellular carcinoma: Given the information which lies in the foundation of the hypothesis of this research, we suggest the use of RNAi against the mRNAs of ITGB1 and CD47 genes in order to hinder or even abort the progression of HCC without significantly impacting the healthy cells.